Extending Outcomes for Pancreas Cancer Patients With Nominal Oligometastatic Disease (EXPAND): A Randomized Phase III Trial
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
NRG Oncology
M.D. Anderson Cancer Center
Case Comprehensive Cancer Center
Alliance for Clinical Trials in Oncology
Fudan University
Memorial Sloan Kettering Cancer Center
Johns Hopkins University
Minia University
Tanta University
Minia University
Memorial Sloan Kettering Cancer Center
Gruppo Oncologico del Nord-Ovest
Thomas Jefferson University
Second Affiliated Hospital, School of Medicine, Zhejiang University
Gustave Roussy, Cancer Campus, Grand Paris
AIO-Studien-gGmbH
Arbeitsgemeinschaft medikamentoese Tumortherapie
Pancreatic Cancer Action Network
University of Liverpool
Alliance for Clinical Trials in Oncology
Changhai Hospital
Sahlgrenska University Hospital
Uppsala University Hospital
Erasmus Medical Center
Elisabethinen Hospital
University of Erlangen-Nürnberg Medical School
Biotech Pharmaceutical Co., Ltd.
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
RenJi Hospital
Fudan University
UNICANCER
Albert Einstein College of Medicine
Fudan University
Fudan University
Centre Oscar Lambret
Karolinska University Hospital
Stanford University
Changhai Hospital
Institute of Molecular Medicine and Biomedical Research
Medical University of Graz
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Istituto Clinico Humanitas
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
University of Zurich
Assistance Publique - Hôpitaux de Paris
Swiss Cancer Institute
Fudan University
Universitätsklinikum Hamburg-Eppendorf